表达数量性状基因座
单核苷酸多态性
生物
数量性状位点
全基因组关联研究
遗传关联
医学
内科学
基因座(遗传学)
血压
SNP公司
遗传学
内分泌学
冠状动脉疾病
基因
生物信息学
基因型
作者
Xingchen Wang,Xingbo Mo,Huan Zhang,Lei Zhang,Yueping Shen
出处
期刊:Current Molecular Medicine
[Bentham Science]
日期:2019-08-28
卷期号:19 (10): 731-738
被引量:7
标识
DOI:10.2174/1566524019666190828151540
摘要
Phosphorylation-related SNP (phosSNP) is a non-synonymous SNP that might influence protein phosphorylation status. The aim of this study was to assess the effect of phosSNPs on blood pressure (BP), coronary artery disease (CAD) and ischemic stroke (IS).We examined the association of phosSNPs with BP, CAD and IS in shared data from genome-wide association studies (GWAS) and tested if the disease loci were enriched with phosSNPs. Furthermore, we performed quantitative trait locus analysis to find out if the identified phosSNPs have impacts on gene expression, protein and metabolite levels.We found numerous phosSNPs for systolic BP (count=148), diastolic BP (count=206), CAD (count=20) and IS (count=4). The most significant phosSNPs for SBP, DBP, CAD and IS were rs1801131 in MTHFR, rs3184504 in SH2B3, rs35212307 in WDR12 and rs3184504 in SH2B3, respectively. Our analyses revealed that the associated SNPs identified by the original GWAS were significantly enriched with phosSNPs and many well-known genes predisposing to cardiovascular diseases contain significant phosSNPs. We found that BP, CAD and IS shared for phosSNPs in loci that contain functional genes involve in cardiovascular diseases, e.g., rs11556924 (ZC3HC1), rs1971819 (ICA1L), rs3184504 (SH2B3), rs3739998 (JCAD), rs903160 (SMG6). Four phosSNPs in ADAMTS7 were significantly associated with CAD, including the known functional SNP rs3825807. Moreover, the identified phosSNPs seemed to have the potential to affect transcription regulation and serum levels of numerous cardiovascular diseases-related proteins and metabolites.The findings suggested that phosSNPs may play important roles in BP regulation and the pathological mechanisms of CAD and IS.
科研通智能强力驱动
Strongly Powered by AbleSci AI